IRIS
BEDINI, ANNALIDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.907
EU - Europa 5.513
AS - Asia 1.885
Continente sconosciuto - Info sul continente non disponibili 22
AF - Africa 21
SA - Sud America 15
OC - Oceania 10
AN - Antartide 1
Totale 15.374
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.859
GB - Regno Unito 2.069
CN - Cina 1.328
IT - Italia 960
UA - Ucraina 888
SE - Svezia 510
TR - Turchia 354
FI - Finlandia 331
DE - Germania 266
IE - Irlanda 190
FR - Francia 75
RU - Federazione Russa 61
IN - India 59
SG - Singapore 52
CA - Canada 46
BE - Belgio 39
NL - Olanda 32
KR - Corea 27
EU - Europa 18
RO - Romania 18
ES - Italia 16
VN - Vietnam 15
JP - Giappone 14
CH - Svizzera 9
HK - Hong Kong 9
PL - Polonia 9
AL - Albania 8
AU - Australia 8
KE - Kenya 8
EG - Egitto 7
BR - Brasile 6
A2 - ???statistics.table.value.countryCode.A2??? 4
IR - Iran 4
PK - Pakistan 4
SI - Slovenia 4
TG - Togo 4
AM - Armenia 3
AT - Austria 3
BD - Bangladesh 3
BG - Bulgaria 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
HU - Ungheria 3
ID - Indonesia 3
IL - Israele 3
BO - Bolivia 2
GU - Guam 2
IQ - Iraq 2
LU - Lussemburgo 2
PE - Perù 2
SA - Arabia Saudita 2
SM - San Marino 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MX - Messico 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 15.374
Salva come PNG Salva come JPEG
Città #
Southend 1.893
Woodbridge 1.169
Fairfield 968
Houston 747
Jacksonville 710
Ann Arbor 677
Chandler 588
Ashburn 455
Cambridge 446
Seattle 378
Wilmington 376
Nanjing 351
Izmir 257
Urbino 251
Dublin 188
Nanchang 152
Helsinki 136
San Mateo 113
Beijing 108
Princeton 106
Shenyang 83
New York 80
Hebei 78
Boardman 75
Changsha 73
Tianjin 71
Düsseldorf 70
Istanbul 62
Jiaxing 52
Kunming 43
Des Moines 41
Brussels 38
Jinan 38
Velikiy Novgorod 38
Bremen 35
Venice 30
Toronto 28
San Diego 27
Hangzhou 26
San Francisco 26
Singapore 26
Shanghai 25
London 24
Seongnam 24
Zhengzhou 23
Ningbo 22
Guangzhou 20
Mülheim 20
Haikou 19
Wuppertal 18
Los Angeles 17
Tavullia 17
Milan 16
Rome 16
Changchun 15
Parma 15
Bologna 14
Lanzhou 14
Amsterdam 13
Norwalk 13
Auburn Hills 11
Augusta 11
Monte Porzio 11
Munich 11
Dong Ket 10
Leawood 10
Mcallen 10
Redwood City 10
Taizhou 10
Dearborn 9
Orange 9
Frankfurt am Main 8
Scottsdale 8
West Jordan 8
Acquasanta Terme 7
Ascoli Piceno 7
Madrid 7
Portland 7
Prescot 7
Tirana 7
Acton 6
Focsani 6
Fuzhou 6
Timisoara 6
Borås 5
Fano 5
Jesi 5
Kiev 5
Kilburn 5
Macerata 5
Monmouth Junction 5
Mumbai 5
Naples 5
Osimo 5
Ancona 4
Angri 4
Calgary 4
Chieti 4
Dormagen 4
Florence 4
Totale 11.730
Salva come PNG Salva come JPEG
Nome #
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 319
Iridium-Catalyzed Direct Synthesis of Tryptamine Derivatives from Indoles: Exploiting N-Protected β-Amino Alcohols as Alkylating Agents 313
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 302
1-Aminocyclopropane-1-carboxylic acid derivatives: Synthesis and NMDA receptor complex binding affinity study. 252
Synthesis of Tryptamine Derivatives via a Direct, One-Pot Reductive Alkylation of Indoles 240
Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties 232
An improved synthesis of cis-4-phenyl-2-propionamidotetralin (4-P-PDOT): a selective MT2 melatonin receptor antagonist. 224
1-Amminocyclopropane-1-Carboxylic Acid Derivatives: A New, General Synthesis and NMDA Receptor Complex Binding Affiniy Study 224
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity 223
Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats 223
Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012-2014) 222
Direct, One-Pot Reductive Alkylation of Anilines with Functionalized Acetals Mediated by Triethylsilane and TFA. Straightforward Route for Unsymmetrically Substituted Ethylenediamine 218
Synthesis and Configuration Determination of All Enantiopure Stereoisomers of the Melatonin Receptor Ligand 4-Phenyl-2-propionamidotetralin using an Expedient Optical Resolution of 4-Phenyl-2-tetralone 216
Synthesis and Characterization of New Bivalent Agents as Melatonin- and Histamine H3-Ligands 209
Synthesis and Biological Activity of new melatonin dimeric derivatives. 206
Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands 203
(E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists. 200
Design, synthesis and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids 195
4,5-Dihydroisoxazole and 4,5-dihydro-1,2,4-oxadiazole derivatives from cycloaddition reactions of nitrile oxides to alkyl N-(diphenylmethylene)-α ,β -dehydroamino acids 192
An improved route to cycloalka[b]pyrrole 2-carboxylates 189
3-(2-Carbamoylvinyl)-4,5-dimethylpyrrole-2-carboxylic acids as ligands at the NMDA glycine-binding site: a study on the 2-carbamoylvinyl chain modification 187
Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines 186
Synthetic Melatonin Receptor Ligands 185
Toward the Definition of Stereochemical Requirements for MT(2)-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives 185
The rationale for the development of melatonin receptor ligands 184
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands. 181
Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy 177
Differentiation between isomeric 1-aminocyclopropane-1-carboxylic acid derivatives by means of chemical ionisation and mass selected collision induced dissociation 176
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand 174
Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety 174
Plant-derived phenolic compounds prevent the DNA single-strand breakage and cytotoxicity induced by tert-butylhydroperoxide via an iron-chelating mechanism. 173
Synthesis, Enantiomeric Resolution and Structure-Activity Relationship Study for a Series of 10,11-Dihydro-5H-dibenzo[a,d]cycloheptene MT2 Receptor Antagonists. 167
Substituent effects on 1,3-dipolar cycloadditions to some 1,1-diphenyl-2-aza-1,3-butadiene derivatives 167
MELATONIN RECEPTOR AGONISTS: SAR AND APPLICATIONS TO THE TREATMENT OF SLEEP-WAKE DISORDERS 165
Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit 165
Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle 165
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 162
Diastereo- and enantioselective hydrogenation of a challenging enamide derived from 4-phenyl-2-tetralone: an appealing shortcut towards enantiopure cis-2-aminotetraline derivatives 162
Selective Melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways 157
Design and synthesis of N-[3,3-diphenyl-propenyl]alkanamides as a novel class of potent MT2-selective Melatonin receptor ligands 155
2,3-Dehydroamino acid derivatives as intermediates in the synthesis of heterocyclic compounds. 155
Bivalent Ligand Approach on N-[2-[(3-methoxyphenyl)methylamino]ethyl]acetamide. Synthesis, Binding Affinity and Intrinsic Acivity for MT(1) and MT(2) melatonin Receptors. 152
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells 152
Recent advances in the development of melatonin MT1 and MT2 receptor agonists 149
Synthesis and conformational study of 3,4-carbocyclic bridged indole melatonin and serotonin analogues 149
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists 148
N-Acyl-5- and -2,5-substituted tryptamines: synthesis, activity and affinity for human mt1 and MT2 melatonin receptors 147
THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP STUDIES ON SELECTED MT1 AND MT2 MELATONIN RECEPTOR LIGANDS: REQUIREMENTS FOR SUBTYPE SELECTIVITY AND INTRINSIC ACTIVITY MODULATION 146
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam 146
Homology models of melatonin receptors: challenges and recent advances 146
N-(Substituted-anilinoethyl)acylamides: Design, Synthesis and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands 145
Reactions of 3-Carbomethoxy-2-aza-1,3-Butadiene Derivatives with Dienophiles 145
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 144
Strategies leading to MT2 selective melatonin receptor antagonists 144
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 144
N-acetiltriptamine 2,5-sostituite: sintesi e valutazione dell’attività biologica per i recettori melatoninergici MT1 e MT2 143
Strategies leading to MT2 selective melatonin receptor antagonists 143
Melatonin receptor agonists: new options for insomnia and depression treatment 142
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models 139
(E)-3-[2-(Carbamoylvinyl)]pyrrol-2-carboxylic acid derivatives: A novel Class of glycine site Antagonists. 137
Progettazione e Sintesi di nuovi ligandi dei recettori MT1 e MT2 della melatonina a struttura difenilalchilammidica. 136
Short synthesis of tryptophan and β -carboline derivatives by reaction of indoles with N-(diphenylmethylene)-α ,β -didehydroamino acid esters 133
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 132
Melatonin, non-selective MT1/MT2 and selective MT2 receptor agonists: differential effects on the 24-hr vigilance states 128
SYNTHESIS, BINDING AFFINITY FOR THE MELATONIN RECEPTOR, AND EVALUATION OF THE BIOLOGICAL ACTIVITY OF NEW INDOLE-BASED MELATONIN ANALOGUES. 127
Synthesis, Pharmacological Characterization and QSAR Studies on 2-Substituted Indole Melatonin Receptor Ligands 127
Synthesis and biological evaluation of 6-bromo-6-substituted penicillanic acid derivatives as beta-lactamase inhibitors. 126
Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities 125
Towards the development of mixed MT1-agonist/MT2-antagonist melatonin receptor ligands 124
ANTIMETASTATIC ACTION OF A NEW ANALOG OF DACARBAZINE IN MICE BEARING LEWIS LUNG CARCINOMA 121
MT2 selective melatonin receptor antagonists. Design and structure activity relationships 120
N-(anilinoethyl)acylamides: new melatonin receptor ligands with sleep inducing properties. 119
MT2 selective melatonin receptor antagonists: design and structure-activity relationships 114
A novel melatonin partial agonist with sleep-promoting properties 113
Synthesis of new 6-bromopenicillanic acid derivatives as potential β-lactamase inhibitors. 112
Antioxidant and cytoprotective activity of indole derivatives related to melatonin, 112
Correlation of the antimetastatic properties of aryltriazenes with their Electron Impact Ionization Mass Spectronomy 109
MT1-Selective Melatonin Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Dynamics Investigation of N-{[(3-O-Substituted)anilino]alkyl}amides 107
Synthesis of new C-6 alkylidene penicillin derivatives as beta-lactamase inhibitors 104
Synthesis, binding and QSAR studies of new 2-substituted melatonergic agonists. 102
INVESTIGATION OF SOME 2,3-DIDEHYDRO AMINOACIFS BY FAST ATOM BOMBARDMENT, CHEMICAL IONIZATION AND MASS-SELECTED COLLISION-INDUCED DISSOCIATION MASS SPECTROMETRY. 102
In vitro metabolism of the melatonin MT2-receptor selective ligand UCM765 by rat, mouse and human liver substrates 101
Analoghi della melatonina: effetto dei sostituenti sull’attività di derivati N-acetiltriptaminici. 100
A novel melatonin partial agonist with sleep promoting properties and anti-anxiety effects. 100
Selective increase of Slow Wave Sleep (SWS) by a novel melatonin partial agonist 100
Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal tumor leukocytes, Toxicology and apllied Pharmacology, 239(1), 37-45 (2009) 96
Synthesis of new 6-alkyliden penicillin derivatives as potential beta-lactamase inhibitors. 95
Selective increase of Slow Wave Sleep (SWS) by melatonin 2 receptors. 92
A novel melatonin partial agonist with sleep-promoting properties. 91
Novel melatonin ligands having antidepressant activity as well as sleep inducine properties 86
2-5-Disubstituted tryptamines a selective serotonin 5HT6 receptor agonists. 85
Design and structure-activity relationships of subtype selective melatonin receptor ligands. 85
STRUCTURAL CHARACTERIZATION OF ISOMERIC DIDEHYDRO AMINOACIDS USING CHEMIAL IONIZATION 85
Antioxidant and cytoprotective effect of indole derivatives related to melatonin 83
Relazioni struttura attività per analoghi indolici della melatonina ad azione antiossidante e citoprotettiva 78
In vitro evaluation of antioxidant activity for a series of 2-acylaminoethylindoles, PBA2004 77
2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT1 and MT2 receptors 76
Design and synthesis of metabolically protected melatonin receptor agonists 74
Razionalizzazione dell’attività di antagonisti MT2 selettivi mediante docking e dinamica molecolare in modelli dei recettori MT1 e MT2 della melatonina. 73
Novel anti-anxiety and sleep-promoting melatonin receptor ligands from modulation of N-anilinoethylamide structure. 71
Totale 15.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.103
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.563 0 0 229 770 154 278 283 258 169 211 87 124
2020/20211.989 61 137 81 267 108 135 119 156 326 225 255 119
2021/20221.284 128 145 125 165 23 35 57 62 86 72 31 355
2022/20231.850 209 122 56 207 163 405 7 165 296 56 122 42
2023/2024565 32 58 28 77 40 100 32 13 67 57 18 43
2024/2025241 136 105 0 0 0 0 0 0 0 0 0 0
Totale 15.617